Boijsen E
Acta Radiol Suppl. 1983;366:180-4.
From previous experimental investigations and from the present clinical experience in more than 2000 examinations it is clear that the adverse reactions of Omnipaque are markedly less when compared with those of conventional contrast media for intravascular use. Similar observations have been made for other low osmolar contrast media. These new media should therefore replace the conventional media for intravascular use. The economical consequences are discussed.
根据以往的实验研究以及目前超过2000例检查的临床经验，很明显，与传统的血管内使用造影剂相比，欧乃派克的不良反应明显更少。对于其他低渗造影剂也有类似的观察结果。因此，这些新型造影剂应取代传统的血管内使用造影剂。文中还讨论了其经济影响。
